Main page Cancer blog Health blog Articles Resources
Subscribe To Cancer Blog RSS Feed 
Gene linked to aggressive prostate cancer
Scientists suspect that the DAB2IP gene is involved in tumor suppression, suggesting that this protective mechanism goes awry in men with the variant form. The finding, reported today in the Journal of the National Cancer Institute, might one day help doctors tailor therapy based on a patients genetic makeup.
Both genetic and environmental factors are important in the development of prostate cancer, and it is only recently that some of the consistent genetic factors have been identified. It is not clear at present whether men who are genetically prone to the disease tend to have more aggressive disease than men who are not.
Because there is no way to tell whether a person has or will have the aggressive version versus the mild version of prostate cancer, both forms are treated the samewith radiotherapy or surgery to remove the prostate gland. The identification of this genetic variant could lead to better risk assessment for aggressive disease, providing doctors with more information on how to best treat men who may be diagnosed with prostate cancer, said John Carpten, Ph.D., director of TGens Division of Integrated Cancer Genomics and senior author of the paper.
Analysis of 3,159 samples led the scientists to conclude that men possessing the DAB2IP variant appear to carry a nearly 36 percent increased risk of advanced prostate cancer.
In most cases, prostate cancer is not a death sentence, but it would be ideal to identify men with an aggressive form of disease, said Jianfeng Xu, M.D., Dr.PH, a senior author and a professor of epidemiology and cancer biology at Wake Forest University School of Medicine. Our finding suggests the possibility of developing a blood test to gauge disease type so doctors could decide if more aggressive therapy is needed.
The scientists screened DNA samples from 500 men with advanced prostate cancer and 500 healthy men of the same age in Sweden. This DNA screening examined the entire genome for more than 550,000 single nucleotide polymorphisms (SNPs), which are locations on chromosomes where a single unit of DNA, or genetic material, may vary from one person to the next. The team then focused on 60,000 SNPs that have also been reviewed by a similar study conducted by the National Cancer Institute (NCI) called Cancer Genetic Markers of Susceptibility (CGEMS). Evaluation of these 60,000 SNPs identified seven SNPs that appeared to be associated with disease aggressiveness.
Additionally, scientists screened another 1,242 men with advanced disease and 917 healthy men who were part of a research project at Johns Hopkins Medical Institutions. This group included both African and European Americans. Through these multiple screenings, the scientists observed that the variant form of DAB2IP is linked to an increased risk of having aggressive disease.
Senior authors Henrik Gronberg, M.D., Ph.D., a professor of epidemiology from Karolinska Institute, and William Isaacs, Ph.D., a professor of urology at Johns Hopkins Medical Institutions, both agree that the findings were possible because advances in technology allow scientists to take a more systematic approach to looking at the entire genome. Instead of solely studying genes that they suspect may be correlation to disease susceptibility, they can study the entire genome and look for associations.
By using state-of-the-art technologies, we can find genes that were not previously known or believed to be involved with disease risk, said David Duggan, Ph.D., head of TGens Advanced Genomics Technology Lab. If we can then learn more about the proteins they produce, it could lead to new understanding about disease mechanisms and new therapys.
Posted by: Jessica Source